noscript

News and Announcements

SUDA Update on HC Berlin Pharma

  • Published June 06, 2016 4:52PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

3rd June 2016, ASX Announcement

SUDA Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, today announces that it has received a Statement of Claim in relation to a lawsuit between the Company and HC Berlin Pharma AG (in liquidation).

A review by our legal advisors in Germany has identified that the Statement of Claim contains assertions that are not based on fact, therefore based on our legal advice, the Directors of SUDA believe that the claim is without significant merit and will be vigorously defended.

In 2008, HC Berlin Pharma entered into an agreement with SUDA (then Eastland Medical Systems Ltd) for certain manufacturing rights. The licence granted to HC Berlin Pharma was subject of an in-kind capital contribution and SUDA was issued with shares in the capital of HC Berlin Pharma in exchange for these rights.

To view the full announcement, please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now